SADULLAH KELEŞ, Deniz Ayzin LEÇE, Anıl ARSLAN, Orhan BAYKAL

Retinal ven tıkanıklığı ile glob aksiyel uzunluk ilişkisi

Retinal ven tıkanıklığı (RVT)'ında da aksiyel uzunluğun risk faktörü olup olmadığı ortaya konulmaya çalışıldı. Santral retinal ven tıkanıklığı (SRVT) olan 12 ve santral retinal ven dal tıkanıklığı (SRVDT) olan 18 hasta olmak üzere, toplam 30 hastanın A scan ultrasonografi ile aksiyel uzunluk ölçümü yapıldı. Aynı yaş grubundan, geçirilmiş santral veya dal retinal ven tıkanıklığı olmayan 30 hasta kontrol grubu olarak alındı. SRVT olan 12 hastanın tıkanıklık olan gözde aksiyel uzunluk değerleri ortalama 22,40±0,22, sağlam gözde 22,58±0,15 mm, SRVDT olan 18 olguda hasta gözde ortalama aksiyel uzunluk 22,70±0,15, diğer sağlam gözde 22,86±0,14 olarak ölçüldü. Kontrol grubunun aksiyel uzunluğu ortalama 23,36±0,10 (min. 22,40, mak.25,11) olarak saptandı. Bu sonuçlar, santral retinal ven ve dal tıkanıklıklarında aksiyel uzunluğun kontrol grubuna göre daha kısa olduğu, bunun ven tıkanıklığı için bir risk faktörü olabileceği düşünüldü.

Anahtar Kelimeler:

Retinal ven tıkanıklığı, Ultrasonografi, Risk faktörleri, Aksiyal uzunluk, göz

The relationship between retinal vein occlusion and axial length of the globe

To evaluate the ocular axial length as a risk factor for development of retinal vein occlusion (RVO). 12 patients with central retinal vein occlusion (CRVO) and 18 patients with branch retinal vein occlusion (BRVO) were studied in regard to their ocular axial lengths by A scan ultrasonography and compared with those of contrlateral unaffected eyes and 30 age matched controls. In 12 patients with CRVO the mean axial length of affected eyes was 22.40±0.22 mm, unaffected eyes was 22.58±0.15 and in 18 patients with BRVO the mean axial length of affected eyes was 22.70±0.15 and of unaffected eyes was 22.86±0.14. The mean axial length of control was 23.36±0.10 (min. 22.40, mak.25.11) These findings suggestted that the axial lengths in CRVO and BRVO were significantly shorter than the control groups and one can be say that this significant difference may be a risk factor in the development of CRVO and BRVO.

Keywords:

Retinal Vein Occlusion, Ultrasonography, Risk Factors, Axial Length, Eye,

PDF

___

1. Kalaycı D, Gürgey A, Güven D, Parlak H Hasıpiri H. Faktör V Leiden and Protrombin 20210 A mutations in patients with control and branch retinal vein occlusion. Acta Ophthalmol Scand 1999;77: 622-4.
2. Hansen L, Kristensen HL, Bek T and Ingerslenv J. Markers trombophilia in retinal vein trombosis. Acta Ophthalmol Scand 2000;78:523-6.
3. Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002;32: 308-11.
4. Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Cerrato GS, Forastiero RR. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 2002;13: 623-6.
5. Simons BD, Brucker AJ. Branch retinal vein occlusion. Axial length and other risk factors. Retina 1997;17: 191-5.
6. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1: 27-55.
7. Timmerman EA, de Lavalette VW, van den Brom HJ. Axial length as a risk factor to branch retinal vein occlusion. Retina 1997;17: 196-9.
8. Tsai SC, Chen HY, Chen CY. Relationship between retinal vein occlusion and axial length. Kaohsiung J Med Sci 2003;19: 453-7.
9. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982;100: 1132.
10. Shahsuvaryan ML, Melkonyan AK. Central retinal vein occlusion risk profile: a case-control study. Eur J Ophthalmol 2003;13: 445-52.
11. şener C, Özdemir O, Oruç S, Eldem B, Kirazlı Ş. Retina ven tıkanıklığına eşlik eden antikoagülan ve fibrinolitik faktör eksiklikleri: Protein C ve protein S. Türk Oft Gaz 1992;22: 371-5.
12. Sperduto RD, Hiller R, Chew E, Siegel D, BlairN, Burton TC, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central andbranch retinal vein occlusion. Ophthalmol 1998;105: 765–71.
13. Fonk ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993;37: 393-417. occlusion. A case-control study. Ophthalmology 1992;99: 509-14.
15. Yazar Z, Nurözler A, Duman S. Santral retinal ven oklüzyonlu olguların değerlendirilmesi. T Oft Gaz 1993;23: 336-40.
16. McGrath MA, VechsIer F, Hunyor AB, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978;138: 216-20.
17. Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 1989;21: 153-7.
18. Green WR, Chan CC, Hutchins GM. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1: 27-55.
19. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P.Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131: 61-77.
20. Green WR. Retinal ischemia vascular and circulatory conditions and diseases. In spensor WH (ed): Ophthalmic Pathology: An Atlas and Textbook, Saunders WB: Philadelphia 1985;2: 655-709.
21. Khan J, Chong V. Two retinal vein occlusions in a patient with venous tortuosity at the optic disc. Graefes Arch Clin Exp Ophthalmol 2005; 21: 1-2.
22. Cekic O, Totan Y, Aydin E, Pehlivan E, Hilmioglu F. The role of axial length in central and branch retinal vein occlusion. Ophthalmic Surg Lasers 1999;30: 523-7.
23. Arıtürk N, Oge Y, Erkan D, Sullu Y, Mohajery F. Relation between retinal vein occlusions and axial length. Br J Ophthalmol 1996;80: 633-6. 24. Talu S, Stefanut C. Axial length and branch retinal vein occlusion. Oftalmologia 2004;48: 81.